Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 726

1.
2.
3.

Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger.

Campagne G, Garba A, Fabre P, Schuchat A, Ryall R, Boulanger D, Bybel M, Carlone G, Briantais P, Ivanoff B, Xerri B, Chippaux JP.

Pediatr Infect Dis J. 2000 Feb;19(2):144-50.

PMID:
10694002
4.

Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults.

Campbell JD, Edelman R, King JC Jr, Papa T, Ryall R, Rennels MB.

J Infect Dis. 2002 Dec 15;186(12):1848-51.

5.

Immune memory in children previously vaccinated with an experimental quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine.

Pichichero M, Papa T, Blatter M, Mitchell D, Kratz R, Sneed J, Bassily E, Casey J, Gilmet G.

Pediatr Infect Dis J. 2006 Nov;25(11):995-1000.

PMID:
17072120
6.

Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents.

Keyserling H, Papa T, Koranyi K, Ryall R, Bassily E, Bybel MJ, Sullivan K, Gilmet G, Reinhardt A.

Arch Pediatr Adolesc Med. 2005 Oct;159(10):907-13.

PMID:
16203934
7.

Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.

Perrett KP, Snape MD, Ford KJ, John TM, Yu LM, Langley JM, McNeil S, Dull PM, Ceddia F, Anemona A, Halperin SA, Dobson S, Pollard AJ.

Pediatr Infect Dis J. 2009 Mar;28(3):186-93. doi: 10.1097/INF.0b013e31818e037d.

PMID:
19209097
8.

Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine.

El Bashir H, Heath PT, Papa T, Ruggeberg JU, Johnson N, Sinha R, Balfour G, Booy R.

Vaccine. 2006 Mar 24;24(14):2544-9.

PMID:
16417952
9.
10.

Safety and immunogenicity of meningococcus serogroup C conjugate vaccine administered as a primary or booster vaccination to healthy four-year-old children.

McVernon J, Maclennan J, Buttery J, Oster P, Danzig L, Moxon ER.

Pediatr Infect Dis J. 2002 Aug;21(8):747-53.

PMID:
12192163
11.

A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.

McVernon J, Nolan T, Richmond P, Reynolds G, Nissen M, Lambert SB, Marshall H, Papa T, Rehm C.

Pediatr Infect Dis J. 2012 Jan;31(1):e15-23. doi: 10.1097/INF.0b013e31823e1e34.

PMID:
22094636
12.
13.

Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants.

Fairley CK, Begg N, Borrow R, Fox AJ, Jones DM, Cartwright K.

J Infect Dis. 1996 Dec;174(6):1360-3.

14.

Safety and immunogenicity of an investigational quadrivalent meningococcal conjugate vaccine after one or two doses given to infants and toddlers.

Halperin SA, Diaz-Mitoma F, Dull P, Anemona A, Ceddia F.

Eur J Clin Microbiol Infect Dis. 2010 Mar;29(3):259-67. doi: 10.1007/s10096-009-0848-8.

PMID:
20033465
15.

The tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic with a clinically acceptable safety profile in subjects previously vaccinated with a tetravalent polysaccharide vaccine.

Dbaibo G, Van der Wielen M, Reda M, Medlej F, Tabet C, Boutriau D, Sumbul A, Anis S, Miller JM.

Int J Infect Dis. 2012 Aug;16(8):e608-15. doi: 10.1016/j.ijid.2012.04.006.

16.

Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age.

Al-Mazrou Y, Khalil M, Borrow R, Balmer P, Bramwell J, Lal G, Andrews N, Al-Jeffri M.

Infect Immun. 2005 May;73(5):2932-9.

17.

Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults.

Southern J, Deane S, Ashton L, Borrow R, Goldblatt D, Andrews N, Balmer P, Morris R, Kroll JS, Miller E.

Clin Diagn Lab Immunol. 2004 Nov;11(6):1100-4.

18.

Induction of immunological memory in UK infants by a meningococcal A/C conjugate vaccine.

Borrow R, Fox AJ, Richmond PC, Clark S, Sadler F, Findlow J, Morris R, Begg NT, Cartwright KA.

Epidemiol Infect. 2000 Jun;124(3):427-32.

19.

A phase II, randomized study on an investigational DTPw-HBV/Hib-MenAC conjugate vaccine administered to infants in Northern Ghana.

Hodgson A, Forgor AA, Chandramohan D, Reed Z, Binka F, Bevilacqua C, Boutriau D, Greenwood B.

PLoS One. 2008 May 14;3(5):e2159. doi: 10.1371/journal.pone.0002159.

Items per page

Supplemental Content

Support Center